钱塘老娘舅

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

A |     AI摘要      处暑虽过鹭岛仍闷热，今明两天受台风及季风影响有大雨到暴雨，气温回落体感转凉。    (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。海上三台共舞，“简拉维”预计今日减弱消散，“紫檀”路径复杂，“沙德尔”后期路径不确定。              昨天我市天气闷热，有雷阵雨。（厦门日报拍客 LMZ 摄）     昨天是二十四节气中的处暑。“处”含有躲藏、终止的意思，从字面上看，这个节气过后，炎热的暑天就要渐渐结束了。昨天也是三伏天的最后一天，今天就要出伏了。但昨天鹭岛依然闷热，雷阵雨也无法彻底驱走暑热。气象部门预测，台风“简拉维”和季风辐合带继续“送水”，今明两天我市有强降水，且强对流易发，气温回落。    预计，今明两天雨势更猛，全市有大雨到暴雨，过程累计雨量达到80毫米～120毫米，局部超过200毫米。降水时局地伴有雷电、短时大风等强对流天气。

B | 气温回落，明天城区最高气温仅剩28℃，夜晨最低气温在25℃左右，体感明显转凉，不过真正的秋凉尚未到来。

C |     海上台风“三台共舞”，路径扑朔迷离。第19号台风“紫檀”未来路径极为复杂，不排除多次登陆的可能。第20号台风“简拉维”预计今天在台湾海峡减弱消散。更远处的第18号台风“沙德尔”预计8月25日前对我国近海海域无影响，后期路径存在较大不确定性。（厦门日报记者 朱道衡 通讯员 崔梦雪）     提醒     注意防范暑热潮湿     处暑节气对闽南农民非常重要，闽南民谚有“处暑不觉热，水果免想结”，“处暑有下雨，中稻粒粒米”的说法。    气象专家提醒，处暑前后，天气还未出现真正意义上的秋凉，此时晴天下午的炎热亦不亚于暑夏之季，空气中仍夹杂着暑湿之邪，所以仍要注意防范暑热、潮湿。处暑后太阳的紫外线辐射指数较大，市民不要忽视防晒。(厦门日报记者 朱道衡 通讯员 林敏丹)。

Current article:http://og6nt5.panningbuquanchencaibingzhang.cyou/news/20260826_4533559.html

Published on:20:17:24